Assessment of biochemical factors in blood serum of patients with oral squamous cell carcinoma.
Copper
Vitamin B 12
folic acid
homocysteine
squamous cell carcinoma of head and neck
Journal
Dental research journal
ISSN: 1735-3327
Titre abrégé: Dent Res J (Isfahan)
Pays: Iran
ID NLM: 101471186
Informations de publication
Date de publication:
2023
2023
Historique:
received:
09
05
2021
revised:
03
08
2022
accepted:
03
05
2023
medline:
7
9
2023
pubmed:
7
9
2023
entrez:
7
9
2023
Statut:
epublish
Résumé
Recently, the role of biochemical factors in the etiology of oral squamous cell carcinoma (OSCC) has attracted some attention. Serum levels of biochemical factors may change in cancer patients. This study aimed to assess the serum level of folate, Vitamin B12, homocysteine, iron, copper, and selenium in patients with OSCC. This descriptive analytical study was conducted on 30 primary OSCC patients (15 males and 15 females) presenting to Imam Khomeini Cancer Institute, who had not yet undergone treatment. Blood samples were taken and serum levels of folate, Vitamin B12, homocysteine, iron, copper, and selenium were measured. Serum levels of micronutrients in patients with different tumor sizes were analyzed by one-way ANOVA. Serum levels of micronutrients were compared among groups with and without metastasis and lymph node involvement using Student's Serum levels of B12, folic acid, homocysteine, copper, iron, and selenium were 232.5 ± 102.68, 8.66 ± 4.06, 18.87 ± 8.81, 96.0 ± 22.64, 55.27 ± 40.58, and 92.47 ± 18.83 ng/mL, respectively. Relatively similar values were measured in patients with different tumor sizes with and without lymph node involvement and presence or absence distant metastasis. However, the serum level of folic acid in OSCC patients without lymph node involvement was significantly higher than that in OSCC patients with lymph node involvement ( Despite some variations, serum levels of micronutrients in OSCC patients were within the normal limits. Considering the variations in serum level of copper in OSCC patients, it may be used as a diagnostic marker. However, further studies are warranted in this respect.
Sections du résumé
Background
UNASSIGNED
Recently, the role of biochemical factors in the etiology of oral squamous cell carcinoma (OSCC) has attracted some attention. Serum levels of biochemical factors may change in cancer patients. This study aimed to assess the serum level of folate, Vitamin B12, homocysteine, iron, copper, and selenium in patients with OSCC.
Materials and Methods
UNASSIGNED
This descriptive analytical study was conducted on 30 primary OSCC patients (15 males and 15 females) presenting to Imam Khomeini Cancer Institute, who had not yet undergone treatment. Blood samples were taken and serum levels of folate, Vitamin B12, homocysteine, iron, copper, and selenium were measured. Serum levels of micronutrients in patients with different tumor sizes were analyzed by one-way ANOVA. Serum levels of micronutrients were compared among groups with and without metastasis and lymph node involvement using Student's
Results
UNASSIGNED
Serum levels of B12, folic acid, homocysteine, copper, iron, and selenium were 232.5 ± 102.68, 8.66 ± 4.06, 18.87 ± 8.81, 96.0 ± 22.64, 55.27 ± 40.58, and 92.47 ± 18.83 ng/mL, respectively. Relatively similar values were measured in patients with different tumor sizes with and without lymph node involvement and presence or absence distant metastasis. However, the serum level of folic acid in OSCC patients without lymph node involvement was significantly higher than that in OSCC patients with lymph node involvement (
Conclusion
UNASSIGNED
Despite some variations, serum levels of micronutrients in OSCC patients were within the normal limits. Considering the variations in serum level of copper in OSCC patients, it may be used as a diagnostic marker. However, further studies are warranted in this respect.
Types de publication
Journal Article
Langues
eng
Pagination
81Informations de copyright
Copyright: © 2023 Dental Research Journal.
Déclaration de conflit d'intérêts
The authors of this manuscript declare that they have no conflicts of interest, real or perceived, financial or nonfinancial in this article.
Références
J Nutr Biochem. 2008 Jan;19(1):1-7
pubmed: 17588734
Perit Dial Int. 2000 Mar-Apr;20(2):169-73
pubmed: 10809239
Cancer. 2005 Jan 15;103(2):284-92
pubmed: 15593092
Int J Cancer. 2003 Feb 20;103(5):664-70
pubmed: 12494476
Ann Oncol. 2006 Mar;17(3):521-5
pubmed: 16344275
Cancer Detect Prev. 2005;29(1):46-53
pubmed: 15734217
Int J Cancer. 2007 Mar 1;120(5):1108-15
pubmed: 17131334
J Oncol. 2018 Dec 18;2018:3720684
pubmed: 30662463
Nutrition. 2000 Jun;16(6):425-8
pubmed: 10869897
Drug Resist Updat. 2000 Aug;3(4):223-235
pubmed: 11498390
Med Sci Monit. 2018 Mar 27;24:1776-1783
pubmed: 29581416
Dent Res J (Isfahan). 2021 Oct 21;18:88
pubmed: 34760079
Int Urol Nephrol. 2010 Mar;42(1):89-93
pubmed: 19548109
Acta Biomed. 2006 Aug;77(2):118-23
pubmed: 17172193
F1000Res. 2020 Apr 2;9:229
pubmed: 32399208
J Int Med Res. 2010;38(6):2047-52
pubmed: 21227009
Talanta. 2003 Aug 29;60(6):1085-95
pubmed: 18969134
Salud Publica Mex. 2009;51 Suppl 2:s172-80
pubmed: 19967272
Nutrition. 2007 Mar;23(3):242-7
pubmed: 17321110
Cancer Epidemiol Biomarkers Prev. 2004 Apr;13(4):511-9
pubmed: 15066913
Nutr Cancer. 2006;56(2):149-57
pubmed: 17474860
Tob Induc Dis. 2019 Apr 12;17:29
pubmed: 31582940
Chem Biol Interact. 2006 Mar 10;160(1):1-40
pubmed: 16430879
Ann Oncol. 2011 Feb;22(2):444-51
pubmed: 20647222
Crit Rev Oncol Hematol. 2002 Apr;42(1):57-64
pubmed: 11923068
Nutrition. 2000 Mar;16(3):189-91
pubmed: 10705073
J Trace Elem Med Biol. 2001;15(2-3):193-6
pubmed: 11787988
Int J Cancer. 2005 Jul 1;115(4):618-24
pubmed: 15704105
Head Face Med. 2006 Oct 16;2:33
pubmed: 17040577
Cancer Causes Control. 2004 Mar;15(2):113-20
pubmed: 15017123